Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)

European Journal of Cancer

Volumn 49, Issue 4, 2013, Pages 868-874

  Park, Jeong Yeol ^a   Kim, Dae Yeon ^a   Kim, Jong Hyeok ^a   Kim, Yong Man ^a   Kim, Kyu Rae ^a   Kim, Young Tak ^a   Seong, Seok Ju ^b   Kim, Tae Jin ^c   Kim, Jae Weon ^d   Kim, Seok Mo ^e   Bae, Duk Soo ^f   Nam, Joo Hyun ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b CHA University   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

^e Chonnam National University Medical School   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Conservative; Endometrial cancer; Fertility sparing; Progestin

Indexed keywords

GESTAGEN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE;

ADULT; ARTICLE; BODY MASS; DISEASE COURSE; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; FEMALE FERTILITY; FOLLOW UP; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PREGNANCY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RECURRENT DISEASE; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA, ENDOMETRIOID; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY PRESERVATION; FOLLOW-UP STUDIES; HUMANS; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREGNANCY; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84873704819     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.09.017     Document Type: Article

References (27)

1. F. Bray, A.H. Loos, M. Oostindier, and E. Weiderpass Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe Int J Cancer 117 2005 123 131
2. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
3. K.W. Jung, S. Park, and Y.J. Won Prediction of cancer incidence and mortality in Korea, 2011 Cancer Res Treat 43 2011 12 18
4. K. Ushijima Current status of gynecologic cancer in Japan J Gynecol Oncol 20 2009 67 71
5. N.H. Jeong, J.M. Lee, and S.K. Lee Current status in the management of uterine corpus cancer in Korea J Gynecol Oncol 21 2010 151 162
6. J.D. Crissman, R.S. Azoury, A.E. Barnes, and H.F. Schellhas Endometrial carcinoma in women 40 years of age or younger Obstet Gynecol 57 1981 699 704
7. D.G. Gallup, and R.J. Stock Adenocarcinoma of the endometrium in women 40 years of age or younger Obstet Gynecol 64 1984 417 420
8. P.T. Soliman, J.C. Oh, and K.M. Schmeler Risk factors for young premenopausal women with endometrial cancer Obstet Gynecol 105 2005 575 580
9. L.R. Duska, A. Garrett, B.R. Rueda, J. Haas, Y. Chang, and A.F. Fuller Endometrial cancer in women 40 years old or younger Gynecol Oncol 83 2001 388 393
10. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 1987 2035 2041
11. R.C. Boronow, C.P. Morrow, and W.T. Creasman Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study Obstet Gynecol 63 1984 825 832
12. E. Seli, and J. Tangir Fertility preservation options for female patients with malignancies Curr Opin Obstet Gynecol 17 2005 299 308
13. P.T. Ramirez, M. Frumovitz, D.C. Bodurka, C.C. Sun, and C. Levenback Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review Gynecol Oncol 95 2004 133 138
14. S. Tangjitgamol, S. Manusirivithaya, and J. Hanprasertpong Fertility-sparing in endometrial cancer Gynecol Obstet Invest 67 2009 250 268
15. S. Erkanli, and A. Ayhan Fertility-sparing therapy in young women with endometrial cancer: 2010 update Int J Gynecol Cancer 20 2010 1170 1187
16. J.P. Kesterson, and J. Fanning Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls J Gynecol Oncol 23 2012 120 124
17. K. Ushijima, H. Yahata, and H. Yoshikawa Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women J Clin Oncol 25 2007 2798 2803
18. W.T. Creasman New gynecologic cancer staging Obstet Gynecol 75 1990 287 288
19. R.B. Greenblatt, R.D. Gambrell Jr., and L.D. Stoddard The protective role of progesterone in the prevention of endometrial cancer Pathol Res Pract 174 1982 297 318
20. C.B. Wang, C.J. Wang, and H.J. Huang Fertility-preserving treatment in young patients with endometrial adenocarcinoma Cancer 94 2002 2192 2198
21. T. Ota, M. Yoshida, M. Kimura, and K. Kinoshita Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger Int J Gynecol Cancer 15 2005 657 662
22. G. Ferrandina, G.F. Zannoni, V. Gallotta, E. Foti, S. Mancuso, and G. Scambia Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report Gynecol Oncol 99 2005 215 217
23. G. Cormio, R. Martino, V. Loizzi, L. Resta, and L. Selvaggi A rare case of choroidal metastasis presented after conservative management of endometrial cancer Int J Gynecol Cancer 16 2006 2044 2048
24. N. Kumar, S.S. Koide, Y. Tsong, and K. Sundaram Nestorone: a progestin with a unique pharmacological profile Steroids 65 2000 629 636
25. A.E. Schindler, C. Campagnoli, and R. Druckmann Classification and pharmacology of progestins Maturitas 46 Suppl 1 2003 S7 S16
26. A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, and M. Zwahlen Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 2008 569 578
27. T. Perri, J. Korach, and W.H. Gotlieb Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved Int J Gynecol Cancer 21 2011 72 78